(C) GMA News
Last updated on May 18th, 2021 at 05:27 am
Abu Dhabi – Hundreds of Filipinos were included among the thousands who volunteered in the Phase III of COVID-19 vaccine trials in the United Arab Emirates.
According the the statement released by the Department of Foreign Affairs, that Group 42 (G42), the bu Dhabi-based technology company, is currently on its human (phase III) trials for the vaccine.
The vaccine in development is also in collaboration by Chinese company Sinopharm at the Abu Dhabi National Exhibition Centre (ADNEC).
Philippine Ambassador to the UAE Hjayceelyn Quintana said that hundreds of Filipino nurses and volunteers took part on the potential COVID-19 vaccine trials.
She visited the Abu Dhabi National Exhibition Centre (ADNEC) and Group 42 Chief Research Officer Dr. Waleed Zaher gave her an overview on the trial process.
The ADNEC trial site, regarded as the biggest trial site in the world, was able to administer the trial vaccine to over 15,000 people with nationalities.
Around 180 Filipino nurses and 1 doctor were involved in the COVID-19 vaccine trials. The United Arab Emirates is one of the first countries to ever conduct Phase III trial for the potential COVID vaccine that is in development by the Chinese pharmaceutical firm, Sinopharm.
A Market Catching Its Breath The Singapore market turned noticeably quieter after the Straits Times Index (STI) went down, reflecting…
In response to a sudden and highly visible spike in strategic naval operations, the attention of the world has been…
The fast naval build-up in the area of Taiwan and Japan is causing the tension of East Asia to be…
The future of Asia in 2026 has an excellent combination of both opportunities and risks: a fresh wave of IPO…
On a dining table, food from many different cultures may look the same, but that is not the case. After…
Asia Power Index 2025 reveals a significant change of the region of Asia, transforming the entire continent. While the struggle…
This website uses cookies.
Read More